Wiiliam A. Boeger

Founder at Chronix Biomedical, Inc.

Consumer Services

Health Technology

Profile

Wiiliam A.
Boeger is the founder who starts Chronix Biomedical, Inc. in 1997, where he currently serves as Director & Director-Business Development.
He was previously Chairman & Chief Executive Officer at Calypte Biomedical Corp.
and held positions as Faculty at Dartmouth College and Principal at Harvard Medical School.
Boeger holds an MBA from Harvard University and an undergraduate degree from Williams College.

Wiiliam A. Boeger active positions

Companies	Position	Start
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Founder	1996-12-31

All active positions of Wiiliam A. Boeger

Former positions of Wiiliam A. Boeger

Companies	Position	End
Harvard Medical School	Corporate Officer/Principal	-
Dartmouth College	Corporate Officer/Principal	-
CALYPTE BIOMEDICAL CORPORATION	Chairman	-

See the detail of Wiiliam A. Boeger's experience

Training of Wiiliam A. Boeger

Williams College	Undergraduate Degree
Harvard University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wiiliam A. Boeger's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Health Technology
Calypte Biomedical Corp. Calypte Biomedical Corp. Medical SpecialtiesHealth Technology Calypte Biomedical Corp. develops, manufactures and distributes vitro testing products, which improves the diagnosis of Human Immunodeficiency Virus infection, sexually transmitted diseases and other chronic diseases. The company's product line includes both point-of-case rapid tests and the BED incidence test. Calypte Biomedical was founded in 1988 and is headquartered in Portland, OR.	Health Technology